Tolmachev V - Search Results

1

Order of amino acids in C-terminal cysteine-containing peptide-based chelators influences cellular processing and biodistribution of 99mTc-labeled recombinant Affibody molecules.

Altai M, Wållberg H, Orlova A, Rosestedt M, Hosseinimehr SJ, Tolmachev V, Ståhl S. Altai M, et al. Among authors: tolmachev v. Amino Acids. 2012 May;42(5):1975-85. doi: 10.1007/s00726-011-0927-x. Epub 2011 May 15. Amino Acids. 2012. PMID: 21573874

2

Closo-dodecaborate(2-) as a linker for iodination of macromolecules. Aspects on conjugation chemistry and biodistribution.

Tolmachev V, Koziorowski J, Sivaev I, Lundqvist H, Carlsson J, Orlova A, Gedda L, Olsson P, Sjöberg S, Sundin A. Tolmachev V, et al. Bioconjug Chem. 1999 May-Jun;10(3):338-45. doi: 10.1021/bc980033s. Bioconjug Chem. 1999. PMID: 10346862

3

Cellular processing of (125)I- and (111)in-labeled epidermal growth factor (EGF) bound to cultured A431 tumor cells.

Orlova A, Bruskin A, Sjöström A, Lundqvist H, Gedda L, Tolmachev V. Orlova A, et al. Among authors: tolmachev v. Nucl Med Biol. 2000 Nov;27(8):827-35. doi: 10.1016/s0969-8051(00)00148-7. Nucl Med Biol. 2000. PMID: 11150717

4

Optimized indirect (76)Br-bromination of antibodies using N-succinimidyl para-[76Br]bromobenzoate for radioimmuno PET.

Höglund J, Tolmachev V, Orlova A, Lundqvist H, Sundin A. Höglund J, et al. Among authors: tolmachev v. Nucl Med Biol. 2000 Nov;27(8):837-43. doi: 10.1016/s0969-8051(00)00153-0. Nucl Med Biol. 2000. PMID: 11150718

5

Comparative biodistribution of the radiohalogenated (Br, I and At) antibody A33. Implications for in vivo dosimetry.

Orlova A, Höglund J, Lubberink M, Lebeda O, Gedda L, Lundqvist H, Tolmachev V, Sundin A. Orlova A, et al. Among authors: tolmachev v. Cancer Biother Radiopharm. 2002 Aug;17(4):385-96. doi: 10.1089/108497802760363187. Cancer Biother Radiopharm. 2002. PMID: 12396703

6

Combined effect of gefitinib ('Iressa', ZD1839) and targeted radiotherapy with 211At-EGF.

Sundberg AL, Almqvist Y, Orlova A, Blomquist E, Jensen HJ, Gedda L, Tolmachev V, Carlsson J. Sundberg AL, et al. Among authors: tolmachev v. Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1348-56. doi: 10.1007/s00259-003-1308-9. Epub 2003 Aug 21. Eur J Nucl Med Mol Imaging. 2003. PMID: 12937952

7

[(111)In]Bz-DTPA-hEGF: Preparation and in vitro characterization of a potential anti-glioblastoma targeting agent.

Sundberg AL, Orlova A, Bruskin A, Gedda L, Carlsson J, Blomquist E, Lundqvist H, Tolmachev V. Sundberg AL, et al. Among authors: tolmachev v. Cancer Biother Radiopharm. 2003 Aug;18(4):643-54. doi: 10.1089/108497803322287736. Cancer Biother Radiopharm. 2003. PMID: 14503960

8

Approaches to improve cellular retention of radiohalogen labels delivered by internalising tumour-targeting proteins and peptides.

Tolmachev V, Orlova A, Lundqvist H. Tolmachev V, et al. Curr Med Chem. 2003 Nov;10(22):2447-60. doi: 10.2174/0929867033456666. Curr Med Chem. 2003. PMID: 14529484 Review.

9

[177Lu]Bz-DTPA-EGF: Preclinical characterization of a potential radionuclide targeting agent against glioma.

Sundberg AL, Gedda L, Orlova A, Bruskin A, Blomquist E, Carlsson J, Tolmachev V. Sundberg AL, et al. Among authors: tolmachev v. Cancer Biother Radiopharm. 2004 Apr;19(2):195-204. doi: 10.1089/108497804323071977. Cancer Biother Radiopharm. 2004. PMID: 15186600

10

Selection and characterization of HER2/neu-binding affibody ligands.

Wikman M, Steffen AC, Gunneriusson E, Tolmachev V, Adams GP, Carlsson J, Ståhl S. Wikman M, et al. Among authors: tolmachev v. Protein Eng Des Sel. 2004 May;17(5):455-62. doi: 10.1093/protein/gzh053. Epub 2004 Jun 18. Protein Eng Des Sel. 2004. PMID: 15208403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

347 results

Search Page

Filters